Case Report: early regression and bladder-intact survival after limited-course immunotherapy-based systemic therapy in two patients with clinically staged bulky muscle-invasive bladder cancer

BackgroundRadical cystectomy remains a standard curative treatment for muscle-invasive bladder cancer (MIBC). Bladder preservation after systemic therapy without immediate surgery remains investigational and requires careful patient selection, rigorous reassessment, and structured surveillance. We r...

Full description

Bibliographic Details
Published in:Frontiers in Immunology
Main Authors: Su Zhang, Hanghao Zhang, Xingwang Dong, Zhen Qi, Yingjun Ma, Hong Chang, Ye Li, Wei Zhang
Format: Article
Language:English
Published: Frontiers Media S.A. 2026-06-01
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2026.1866469/full